29 Jul FluGen and UK’s Arecor Receive Funding Award
Posted at 15:58h
in Resident Company News
Arecor Ltd of Cambridge, England received the “green light” and funding to pursue a research project applying Arecor’s innovative Arestat™ formulation technology to a promising flu vaccine, REDEE FLU™, developed by FluGen, Inc., of Madison, WI. The UK’s innovation agency, the Technology Strategy Board, has awarded Arecor a Proof of Concept award through its Smart programme, to engage in research and development in the strategically important area of developing a stable formulation for REDEE FLU™. Read more [more-link]